General Information of the Compound
Compound ID
CP0501229
Compound Name
4-(4-methoxyphenoxy)-2-(4-propan-2-ylphenyl)pyridazin-3-one
    Show/Hide
Structure
Formula
C20H20N2O3
Molecular Weight
336.391
Canonical SMILES
COc1ccc(Oc2ccnn(-c3ccc(cc3)C(C)C)c2=O)cc1
    Show/Hide
InChI
InChI=1S/C20H20N2O3/c1-14(2)15-4-6-16(7-5-15)22-20(23)19(12-13-21-22)25-18-10-8-17(24-3)9-11-18/h4-14H,1-3H3
    Show/Hide
InChIKey
JTXWFQZTQZHURL-UHFFFAOYSA-N
Physicochemical Property
logP
4.1568
Rotatable Bonds
5
Heavy Atom Count
25
Polar Areas
53.35
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71452491
SID: 163479218
ChEMBL ID
CHEMBL2207113
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06160, Neuropeptides B/W receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS